Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000276921 | SCV000342294 | uncertain significance | not provided | 2016-05-19 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000276921 | SCV000883438 | likely benign | not provided | 2018-06-28 | criteria provided, single submitter | clinical testing | The ATP7B c.3786C>T; p.Val1262Val variant (rs375007352), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 288242). This variant is found in the general population with an overall allele frequency of 0.005% (13/277214 alleles) in the Genome Aggregation Database. This is a synonymous variant in a weakly conserved nucleotide, and computational analyses (Alamut v.2.11) predict that this variant does not alter splicing. Based on available information, this variant is considered to be likely benign. |
Labcorp Genetics |
RCV001082927 | SCV001075734 | likely benign | Wilson disease | 2024-01-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000276921 | SCV001747084 | likely benign | not provided | 2021-03-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001082927 | SCV001977540 | likely benign | Wilson disease | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002348016 | SCV002620463 | likely benign | Inborn genetic diseases | 2021-12-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV001082927 | SCV004844603 | likely benign | Wilson disease | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001082927 | SCV001454149 | uncertain significance | Wilson disease | 2020-01-24 | no assertion criteria provided | clinical testing |